Related Experiment Video
Updated: Aug 15, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1)
Lu Li1,2, Bi-Feng Chen3,4, Wai-Yee Chan5,6
1The Chinese University of Hong Kong-Chinese Academy of Sciences Guangzhou Institute of Biomedicine and Health Joint Laboratory on Stem Cell and Regenerative Medicine, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China. s1155025779@cuhk.edu.hk.
Abstract:
DNA methylation is an important form of epigenetic regulation in both normal development and cancer. Methyl-CpG-binding domain protein 1 (MBD1) is highly related to DNA methylation. Its MBD domain recognizes and binds to methylated CpGs. This binding allows it to trigger methylation of H3K9 and results in transcriptional repression. The CXXC3 domain of MBD1 makes it a unique member of the MBD family due to its affinity to unmethylated DNA. MBD1 acts as an epigenetic regulator via different mechanisms, such as the formation of the MCAF1/MBD1/SETDB1 complex or the MBD1-HDAC3 complex. As methylation status always changes along with carcinogenesis or neurogenesis, MBD1 with its interacting partners, including proteins and non-coding RNAs, participates in normal or pathological processes and functions in different regulatory systems. Because of the important role of MBD1 in epigenetic regulation, it is a good candidate as a therapeutic target for diseases.
More Related Videos
Related Concept Videos
Epigenetic Regulation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Spreading of Chromatin Modifications
Writers
The writer...
Master Transcription Regulators
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...

